Home > Insider Trading > Filing (0001209191-14-033073)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1559053	Prothena Corp Plc	PRTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1564371	B. Dale Schenk	Prothena Corporation Plc 650 Gateway Boulevard South San Francisco CA 94080	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares, Par Value $0.01 Per Share	Acquisiton	2014-05-12	2,100	$20.23	2,261	No	4	P	Direct
Ordinary Shares, Par Value $0.01 Per Share	Acquisiton	2014-05-12	5,900	$20.99	8,161	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares, Par Value $0.01 Per Share	50	Indirect	By Trust

Footnotes

The shares were purchased in multiple trades at prices ranging from $19.71 to $20.70 inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
The shares were purchased in multiple trades at prices ranging from $20.79 to $21.00 inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
Shares are held by the Schenk Family Trust dated 2/9/2004, of which Reporting Person is a trustee.